Target intelligence / Profile preview

WD repeat domain phosphoinositide-interacting protein 3 (WDR45B)

Target
WDR45B
Molecular classification
WD repeat protein (β-propeller structure), Autophagy effector protein, Scaffold protein (component of large multiprotein complexes)
01

Overview

WD repeat domain phosphoinositide-interacting protein 3 (WDR45B) is a key component of the autophagy machinery. It contains seven WD40 repeats that form a β-propeller structure, serving as a scaffold for protein–protein interactions within autophagy-related multiprotein complexes. WDR45B binds phosphoinositides, mainly phosphatidylinositol 3-phosphate, and is recruited to the endoplasmic reticulum and nascent autophagosomes where it promotes autophagosome membrane elongation downstream of WIPI2. WDR45B is regulated by AMPK and TSC1/TSC2 complex during cellular starvation and interacts with RB1CC1/FIP200. It is crucial for neuronal homeostasis, and its deficiency impedes autophagosome generation, causing accumulation of damaged proteins and aggregates, particularly in neurons. Mutations in WDR45B lead to neurodevelopmental and neurodegenerative disorders, including intellectual disability and spastic quadriplegia, and also play roles in cancer progression, especially hepatocellular carcinoma.

Other names
WDR45BWDR45LWIPI3WIPI-3WD repeat-containing protein 45-likeWD repeat-containing protein 45BWDR45-like proteinWIPI49-like proteinNEDSBASWIPI3 longWD repeat protein 45-like
02

Mechanism of action

mTOR inhibition (restores autophagy suppressed by WDR45B knockdown). Small molecule modulation of WD-repeat scaffold domains (potential pharmacological targeting as outlined for WD-repeat family).

03

Biological functions

Autophagy (autophagosome formation, cargo recognition, and membrane extension)Protein–protein interactions (mediates interactions for autophagy complex assembly)mTOR signaling pathway regulationPhospholipid binding (especially phosphatidylinositol-3-phosphate)
04

Disease associations

Neurodevelopmental disorders (including intellectual disability and neurodegenerative conditions)Cancer (promotes proliferation and migration in hepatocellular carcinoma; altered methylation linked to tumorigenesis)Other diseases (potential association with airway remodeling and asthma response)
05

Safety considerations

Deficiency may lead to severe neuronal degeneration, intellectual disability, and movement disordersImpact on cell proliferation and migration raises concerns about cancer progression
06

Interacting drugs

Rapamycin
07

Biomarkers

DNA methylation of WDR45B (predictive of HCC prognosis)Autophagy activity markers (e.g., LC3, SQSTM1 accumulation in WDR45B deficiency)

Beyond the preview

Go deeper on WD repeat domain phosphoinositide-interacting protein 3 (WDR45B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WD repeat domain phosphoinositide-interacting protein 3 (WDR45B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call